Stock data
BriaCell Therapeutics Corp. (BCTX)
BriaCell Therapeutics Corp. (BCTX) reported net income of -US$26.31M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-07-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$27.20M | -US$26.31M | — |
| 2024 | — | — | -US$33.33M | -US$4.79M | — |
| 2023 | — | — | -US$23.27M | -US$20.30M | — |
| 2022 | — | — | -US$15.29M | -US$26.84M | — |
| 2021 | — | — | -US$6.98M | -US$13.82M | — |
Quarterly results
Data as of 2026-04-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-04-30 | — | -US$7.16M | — |
| 2026-01-31 | — | -US$7.22M | — |
| 2025-10-31 | — | -US$8.20M | — |
| 2025-07-31 | — | -US$8.09M | — |
| 2025-04-30 | — | -US$6.13M | — |
| 2025-01-31 | — | -US$6.29M | — |
| 2024-10-31 | — | -US$5.80M | — |
| 2024-07-31 | — | -US$1.21M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.